OR WAIT null SECS
June 06, 2023
invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines.
Lonza will gain access to R&D capabilities, including payload and site-specific linker technology, through its acquisition of ADC company, Synaffix.
In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.
June 05, 2023
Reimbursement for Alzheimer's medicines still will occur only with the completion of studies to support full FDA approval.
Adamis Pharmaceuticals announced the closing of its merger with DMK Pharmaceuticals on May 25, 2023.
FDA has published a new system for providing basic and essential information on patient use of drugs and certain biologic products.
June 02, 2023
The future is set to be a running theme for this year’s CPHI event, which will take place in-person at the Fira Barcelona Gran Via in Spain between 24–26 October 2023.
Despite being a relatively small nation, Switzerland is booming for biotech innovation.
Here is a small selection of some of the inspiring places to visit while in Barcelona, Spain.
Vaccine nationalism strengthens viruses and poses deadly risks for all involved.
